C9025 – Injection, ramucirumab, 5 mg
HCPCS Level II code · C codes: Outpatient PPS (Hospital Outpatient)
HCPCS codeC9025
- Long description
- Injection, ramucirumab, 5 mg
- Short description
- Injection, ramucirumab
- Pricing indicator
53Statute- Medicare coverage
DSpecial coverage instructions apply- BETOS category
O1DChemotherapy- Cross reference
- J9308
- Added
- October 1, 2014
- Last change
- January 1, 2016 – No change
- Termination date
- December 31, 2015
Frequently asked questions
What is HCPCS code C9025?
C9025 is a HCPCS Level II code for injection, ramucirumab, 5 mg. It was discontinued on December 31, 2015.
Does Medicare cover C9025?
The HCPCS file lists coverage code D: Special coverage instructions apply. Coverage and payment also depend on local coverage determinations and the patient’s plan.
Nearby C codes
- C8957 – Intravenous infusion for therapy/diagnosis; initiation of prolonged infusion (more than 8 hours), requiring use of portable or implantable pump
- C9014 – Injection, cerliponase alfa, 1 mg
- C9015 – Injection, c-1 esterase inhibitor (human), haegarda, 10 units
- C9016 – Injection, triptorelin extended release, 3.75 mg
- C9021 – Injection, obinutuzumab, 10 mg
- C9022 – Injection, elosulfase alfa, 1mg
- C9023 – Injection, testosterone undecanoate, 1 mg
- C9024 – Injection, liposomal, 1 mg daunorubicin and 2.27 mg cytarabine
- C9026 – Injection, vedolizumab, 1 mg
- C9027 – Injection, pembrolizumab, 1 mg
- C9028 – Injection, inotuzumab ozogamicin, 0.1 mg
- C9029 – Injection, guselkumab, 1 mg
- C9030 – Injection, copanlisib, 1 mg
- C9031 – Lutetium lu 177, dotatate, therapeutic, 1 mci
- C9032 – Injection, voretigene neparvovec-rzyl, 1 billion vector genome
- C9033 – Injection, fosnetupitant 235 mg and palonosetron 0.25 mg
Source: CMS HCPCS Level II quarterly file, October 2026. Reference only – check payer policy before billing.